Energy Waveforms and Dosing
Because first shock efficacy for monophasic shocks is lower than first shock efficacy for biphasic shocks , the AHA 2005 Guidelines recommend different initial shock dosages for monophasic defibrillators (360 Joules [J]) and biphasic defibrillators (150-200J). The Guidelines also recommend subsequent biphasic doses at "equal or higher" energy settings.
Clinical evidence shows the limitations of 200J and the benefits of having full energy biphasic available.
A recent out-of-hospital study showed that when energy dosage is limited to 200J biphasic, up to 12% of patients will fail to defibrillate. A separate large out-of-hospital study showed that availability of higher dosage (up to 360J) was associated with a much lower rate of failure (just 0.5% of 416 patients) and good survival (27%).
Challenges
- Will your responders always know which kind of device they are using-monophasic or biphasic?
- Will they be familiar with the appropriate protocol for either type of technology?
- Do your defibrillators provide higher dosage-beyond 200J-for difficult-to-treat patients?
Meeting the Challenges
By standardizing your hospital with the LIFEPAK family of defibrillators you can proactively address each of these challenges. LIFEPAK defibrillators use ADAPTIV™ biphasic technology, giving you a full range of energy dosing up to 360J and a dosing protocol that many responders are already familiar with from the traditional monophasic protocols.